Abera Bioscience AB is a Swedish biotech company headquartered in Uppsala. We are dedicated to develop novel mucosal vaccines based on proprietary vaccine platforms to improve health worldwide.

Abera's platforms allows the development of efficient multivalent, multi-stage vaccines for oral and nasal administration. It also enables faster and more cost-effective production. Abera's OMV-based vaccines can be manufactured within 14-30 days.

Biotechnology

Health Care

Life Sciences

Abera Bioscience AB

Abera Bioscience AB's headquarters in Uppsala, Sweden

Description

People (5)

Maria Alriksson

Mats Lundgren

Ann-Christin Magnusson

Anders Ericson

Cristina Glad

Jobs